论文信息 - Initial Results of a Randomized Phase II Study of Low Dose Decitabine (DAC) Versus Low Dose Azacitidine (AZA) in Patients with Low- or Intermediate-1-Risk Myelodysplastic Syndromes (MDS) - 字舞流文

Initial Results of a Randomized Phase II Study of Low Dose Decitabine (DAC) Versus Low Dose Azacitidine (AZA) in Patients with Low- or Intermediate-1-Risk Myelodysplastic Syndromes (MDS)

Z. Estrov | H. Kantarjian | G. Garcia-Manero | Xuelin Huang | T. Kadia | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | N. Pemmaraju | K. Sasaki | Darla Miller | Victoria Sukholutsky